Novalar has developed NV101, a novel compound that is the only local anesthetic reversal agent that accelerates the return to normal sensation and function following restorative and periodontal maintenance procedures. Novalar has contracted with the leading North American supplier of dental anesthesia cartridges to manufacture NV-101. NV-101 treated patients reported the return of sensation and function in less than half the time it normally took after receiving local dental anesthesia. NV-101 induced a 54.8 percent and a 62.3 percent decrease in time to normal for those with anesthesia administered in the mandible and maxilla respectively.
Welcome to OsseoTECH, a site devoted to chronicling osseointegration developments Please send suggestions for features.